Emstopa
Pre-clinicalEmstoPA is an antibody-based reversal agent to treat bleeding caused by tPA, the “clot buster” used to treat stroke, pulmonary embolism and infarctions.
Founded
2020
Focus
AntibodiesBiologics
About
EmstoPA is an antibody-based reversal agent to treat bleeding caused by tPA, the “clot buster” used to treat stroke, pulmonary embolism and infarctions.
Company Info
TypePrivate
Founded2020
LocationLondon, United Kingdom
StagePre-clinical
Contact
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile